Emergence of Integrase Resistance Mutations During Initial Therapy Containing Dolutegravir. [electronic resource]
Producer: 20191024Description: 791-794 p. digitalISSN:- 1537-6591
- Antiretroviral Therapy, Highly Active
- Drug Resistance, Viral
- Genotype
- HIV Infections -- drug therapy
- HIV Integrase Inhibitors -- therapeutic use
- HIV-1 -- drug effects
- Heterocyclic Compounds, 3-Ring -- therapeutic use
- Humans
- Integrases -- genetics
- Male
- Middle Aged
- Mutation
- Oxazines
- Piperazines
- Pyridones
- Sequence Analysis, DNA
- Treatment Failure
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.